• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Day One Biopharmaceuticals, Inc. - Common Stock (NQ:DAWN)

21.53 UNCHANGED
Last Price Updated: 4:00 PM EDT, Apr 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Day One Biopharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN)
April 09, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN
March 26, 2026
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Halper Sadeh LLC is Investigating Whether DAWN, SEM, EWCZ, FONR are Obtaining Fair Deals for their Shareholders
March 12, 2026
From Halper Sadeh LLC
Via GlobeNewswire
Day One Biopharmaceuticals Inc (NASDAQ:DAWN) Reports Q4 Revenue Beat but Wider Loss, Shares Dip ↗
February 24, 2026
Via Chartmill
News headline image
Halper Sadeh LLC is Investigating Whether DAWN, KORE, CECO are Obtaining Fair Deals for their Shareholders
March 10, 2026
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Talkspace, Inc. (Nasdaq - TALK), Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN), Kennedy-Wilson Holdings, Inc. (NYSE - KW), United Homes Group, Inc. (Nasdaq - UHG)
March 09, 2026
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
The $12.3 Billion Dawn: A Comprehensive Research Feature on Dayforce Inc. (DAWN)
March 09, 2026
On March 9, 2026, the landscape of the Human Capital Management (HCM) software industry looks markedly different than it did just a few years ago. At the center of this transformation is Dayforce Inc.... 
Via Finterra
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Day One Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Day One Biopharmaceuticals, Inc. - DAWN
March 06, 2026
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Stock Market Today, March 6: Energy Stocks Rise as Oil Closes Over $90 on Middle East Tensions ↗
March 06, 2026
Energy names climb while most U.S. stocks retreat on stagflation fears and war-driven oil gains, today, March 6, 2026. 
Via The Motley Fool
Topics Economy Stocks
Here are the top movers in Friday's session. ↗
March 06, 2026
Via Chartmill
Which stocks are moving on Friday? ↗
March 06, 2026
Via Chartmill
News headline image
DAWN Stock Alert: Halper Sadeh LLC is Investigating Whether Day One Biopharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders
March 06, 2026
From Halper Sadeh LLC
Via Business Wire
The market is filled with gapping stocks in Friday's session. ↗
March 06, 2026
Via Chartmill
News headline image
Why Did DAWN Skyrocket Over 65% Pre-Market Today? ↗
March 06, 2026
Pharma firm Servier is set to acquire Day One Biopharmaceuticals’ shares for $21.50 each in cash, valuing the deal at $2.5 billion. 
Via Stocktwits
News headline image
Servier and Day One Biopharmaceuticals announce acquisition to expand Servier’s rare oncology portfolio
March 06, 2026
From Day One Biopharmaceuticals, Inc.
Via GlobeNewswire
News headline image
DAWN Shares Rally On Buyout Speculation But Retail Warns A Deal Might Not Materialise ↗
March 04, 2026
On Stocktwits, retail sentiment around DAWN stock stayed within the ‘extremely bullish’ territory over the past 24 hours. 
Via Stocktwits
Topics Economy
News headline image
Day One Bio (DAWN) Q4 2025 Earnings Transcript ↗
February 24, 2026
Day One Bio (DAWN) Q4 2025 Earnings Transcript 
Via The Motley Fool
News headline image
Day One Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms 2026 Outlook and Revenue Guidance
February 24, 2026
From Day One Biopharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Day One To Report Fourth Quarter and Full-Year 2025 Financial Results Tuesday, February 24, 2026
February 10, 2026
From Day One Biopharmaceuticals, Inc.
Via GlobeNewswire
News headline image
AIGH Capital Dumps 2.6 Million Lumen Technologies Shares In $15.6 Million Exit ↗
February 03, 2026
This telecom provider delivers fiber, cloud, and security services to businesses and consumers across U.S. and international markets. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
Keep an eye on the top gainers and losers in Monday's session. ↗
January 12, 2026
Via Chartmill
Gapping stocks in Monday's session ↗
January 12, 2026
Via Chartmill
Top movers in Monday's pre-market session ↗
January 12, 2026
Via Chartmill
News headline image
Day One Announces Preliminary 2025 OJEMDA™ Net Product Revenue And Provides 2026 Net Product Revenue Guidance
January 11, 2026
From Day One Biopharmaceuticals, Inc.
Via GlobeNewswire
Curious about the stocks that are showing activity after the closing bell on Friday? ↗
January 09, 2026
Via Chartmill
News headline image
Day One Completes Acquisition of Mersana Therapeutics
January 06, 2026
Acquisition expands Day One’s pipeline with clinical-stage antibody drug conjugate (ADC) emiltatug ledadotin (Emi-Le) targeting rare cancer adenoid cystic carcinoma (ACC) 
From Day One Biopharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Day One to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025
From Day One Biopharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Day One Announces Three Year Follow-Up Data From OJEMDA™ (tovorafenib) Phase 2 FIREFLY-1 Trial at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting
November 24, 2025
From Day One Biopharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 18, 2025
From Day One Biopharmaceuticals, Inc.
Via GlobeNewswire
News headline image
Mersana Therapeutics Stock Explodes Over 200% To Notch Best Day Ever As $285M Buyout Trumps Analyst Downgrades: Retail Cheers ‘Very Good Bargain’ ↗
November 14, 2025
Mersana surged even as multiple firms downgraded the stock following Day One’s acquisition agreement. 
Via Stocktwits
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap